» Articles » PMID: 7853484

The Human Immunodeficiency Virus Type 1 Vpu Protein Specifically Binds to the Cytoplasmic Domain of CD4: Implications for the Mechanism of Degradation

Overview
Journal J Virol
Date 1995 Mar 1
PMID 7853484
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

We have recently demonstrated that coexpression of Vpu and CD4 in HeLa cells results in the degradation of CD4 in the endoplasmic reticulum. The sensitivity of CD4 to Vpu-mediated degradation is conferred by the presence of specific sequences located between amino acids 402 and 420 in the CD4 cytoplasmic domain. Using an in vitro translation system, we also showed that degradation of CD4 by Vpu requires the two proteins to be present in the same membrane compartment. Although these results suggest that spatial proximity between CD4 and Vpu may be critical in triggering degradation, it remains unknown whether the two molecules have the ability to interact with each other. In order to better define the mechanisms involved in CD4 degradation, we investigated the existence and functional relevance of direct interactions between CD4 and Vpu. Coimmunoprecipitation experiments showed that Vpu specifically binds to the cytoplasmic tail of CD4. This phenomenon is relevant to the mechanism of CD4 degradation since the ability of CD8/CD4 chimeric molecules and various CD4 mutants to form complexes with Vpu correlates with their sensitivity to degradation. Accordingly, we found that amino acid residues in the CD4 cytoplasmic tail previously shown to be important for degradation are necessary for Vpu binding. We further demonstrate that a deletion mutant of Vpu as well as a phosphorylation mutant, both biologically inactive with regard to CD4 degradation, retained the capacity to interact with the CD4 cytoplasmic domain. Taken together, these results indicate that Vpu binding is necessary to trigger CD4 degradation. However, the binding to target molecules is not sufficient per se to cause degradation. Interaction between CD4 and Vpu is thus likely to be an early event critical in triggering a multistep process leading to CD4 degradation.

Citing Articles

Detection of the HIV-1 Accessory Proteins Nef and Vpu by Flow Cytometry Represents a New Tool to Study Their Functional Interplay within a Single Infected CD4 T Cell.

Prevost J, Richard J, Gasser R, Medjahed H, Kirchhoff F, Hahn B J Virol. 2022; 96(6):e0192921.

PMID: 35080425 PMC: 8941894. DOI: 10.1128/jvi.01929-21.


HIV-1 Envelope Glycoprotein Cell Surface Localization Is Associated with Antibody-Induced Internalization.

Anand S, Prevost J, Descoteaux-Dinelle J, Richard J, Nguyen D, Medjahed H Viruses. 2021; 13(10).

PMID: 34696383 PMC: 8539245. DOI: 10.3390/v13101953.


Designed Ankyrin Repeat Protein (DARPin) to target chimeric antigen receptor (CAR)-redirected T cells towards CD4 T cells to reduce the latent HIV cell reservoir.

Patasic L, Seifried J, Bezler V, Kaljanac M, Schneider I, Schmitz H Med Microbiol Immunol. 2020; 209(6):681-691.

PMID: 32918599 PMC: 7568711. DOI: 10.1007/s00430-020-00692-0.


Plasma Membrane-Associated Restriction Factors and Their Counteraction by HIV-1 Accessory Proteins.

Ramirez P, Sharma S, Singh R, Stoneham C, Vollbrecht T, Guatelli J Cells. 2019; 8(9).

PMID: 31480747 PMC: 6770538. DOI: 10.3390/cells8091020.


Beyond Channel Activity: Protein-Protein Interactions Involving Viroporins.

To J, Torres J Subcell Biochem. 2018; 88:329-377.

PMID: 29900504 PMC: 7122450. DOI: 10.1007/978-981-10-8456-0_15.


References
1.
Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T . T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature. 1984; 312(5996):767-8. DOI: 10.1038/312767a0. View

2.
Willey R, Maldarelli F, Martin M, Strebel K . Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J Virol. 1992; 66(1):226-34. PMC: 238279. DOI: 10.1128/JVI.66.1.226-234.1992. View

3.
Maddon P, Dalgleish A, McDougal J, Clapham P, Weiss R, Axel R . The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell. 1986; 47(3):333-48. DOI: 10.1016/0092-8674(86)90590-8. View

4.
Hoxie J, Alpers J, Rackowski J, Huebner K, Haggarty B, Cedarbaum A . Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. Science. 1986; 234(4780):1123-7. DOI: 10.1126/science.3095925. View

5.
Deen K, McDougal J, Inacker R, Folena-Wasserman G, Arthos J, Rosenberg J . A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature. 1988; 331(6151):82-4. DOI: 10.1038/331082a0. View